| MEDICATION
[ back
to Medication Main Page ]
HEADACHE
Following closed head injury, headache is the most common
and one of the most persistent complaints made to doctors.
In TBI patients, effortful concentration often triggers headache,
limiting time spent reading, studying or doing cognitive remediation
exercises. Headache (especially chronic daily headache and
migraine) can be disabling in the absence of medication, since
they cause insomnia, fatigue, depression and cognitive decline.
Medications which boost serotonin (such as triptans) can reverse
or reduce such symptoms in many but not all sufferers. See,
Headache 40(8):638-646.
Medication, no matter how potent, is not enough. Chronic headache
sufferers must undergo counseling and behavioral change to
identify and avoid headache triggers, increase control over
headache onset and gain confidence in their own ability to
prevent and manage their headaches. See, Headache 40(8):647-655.
Patients who have no prevention strategy or those who over-medicate
(and thus cause "rebound" headaches) feel themselves
at the mercy of their headaches, and tend to feel pessimistic
and depressed. Patients who fail to keep headache diaries
cannot learn to identify and avoid headaches triggers. For
example, headache sufferers who cannot give up red wine, can
reduce triggering red wine headache by looking at wine labels
and avoiding those which contain sulfites. Working closely
with a neurologist who sub-specializes in headache management
is critical to recovery from TBI in those patients who suffer
intensely from headache. Recent literature indicates that
the #1 long term complaint of persons with "mild"
TBI is headache.
The choice of medication depends of the cause. The traumatic
event which causes the TBI can simultaneously trigger one
or more type of headache, including myofascial (from tension
in cervical or scalp muscles), cervical (from spinal subluxation
or disc herniation in the neck), migraine, cluster and others.
For mild to moderate muscle tension headaches, aspirin, ibuprofen
or tylenol can help (especially when consumed with a cup of
coffee to increase absorption rate in the stomach). Midrin
is a good combination pill containing anti-inflammatory and
pain medicine with caffeine. For more severe muscle tension
headaches, trigger point injections of steroids or Botox along
with a more powerful analgesic like Vicodin may be required.
For migrainous headache (one-sided, throbbing headache accompanied
by nausea, fatigue and hypersensitivity to light or noise)
analgesics are often combined with vaso-constrictors to narrow
the dilated blood vessels. These include preparations like
Fiorinal. Very severe pain can be medicated with Darvon at
home or with DHE-45, Demerol, Stadol or various cortico-steroids
at the doctor's office. Intra-nasal administration of lidocaine,
a local anesthetic, shows promise for lasting pain relief.
A recent study found that some migraine patients benefit from
injections of Botox (botulinum toxin) to selected places on
the face. Migraineurs with frequent headaches may benefit
from prophylatic medications to limit the number of headaches.
These include tricyclic anti-depressants (Elavil, Pamelor
or Sinequan) and Depakote (a gabapentin preparation used as
an anti-convulsant).
A relatively new family of medications called "triptans"
(5HT agonists which increase the supply of serotonin) have
proven extremely effective in stopping or "aborting"
migraines already in progress. These include Imitrex, Amerge,
Zomig, Maxalt and Relpax. The triptans are so effective they
are being hailed by many neurologists as a near miraculous
breakthrough in migraine relief. A key to successful use of
triptans is rapid administration. Low dose administration
of a triptan during the early phase of a migraine, before
it becomes excruciating or incapacitating, appears to work
best. Patients with migraine are encouraged to fill out a
disability questionnaire (such as the Midas Migraine questionnaire
at www.midas-
migraine.net). A 2 year study on treatment of acute migraine
conducted between 1997-1999 in 88 clinical centers across
13 countries shows that "stratified care" works
much better than "step care" for migraine. In the
stratified approach, patients who assess themselves with a
high level of disability from migraine, should be placed immediately
on triptans. The older approach (based on cost) was to take
all migraine patients and bring them up the ranks of medication
in step-wise fashion from the cheaper more generic meds to
the more expensive, boutique medicines formulated specifically
for severe migraine. See Lipton RB et al. "Stratified
care vs. step care strategies for migraine" JAMA 2000;284:2599-2605.
Patients who do not respond well to one triptan should not
give up. Research shows that non-responders to Imitrex, may
respond very well to another triptan due to slight differences
in the molecular structure of the medications. Each triptan
has its own unique side effect profile. Commonly reported
side effects include dizziness, nausea and tiredness. The
very newest triptan, to be marketed in the USA in 2001, is
almoptriptan or Axert. The studies submitted to the FDA show
that Axert has a lower incidence of these side effects than
other triptans. When a patient decides to switch from one
triptan to another, he should allow 2 weeks off medication
before switching to avoid the potentially serious problems
that go with mixing medications. Great care should be used
with these drugs in anyone with coronary artery disease.
Oral medication is not the only method of aborting a migraine
in progress. Inra-nasal administration of lidocaine has proven
very effective in some migraine sufferers. Injections of lysine
clonixinate (a nicotinic acid derivative marketed under such
names as Dolamine, Solnot, Clonix and Deltar) was touted as
a highly effective means to control migraine pain at the Winter
2000 Conference of Neurology in Brazil. For patients with
acute migraine who are highly nauseated and vomiting, and
who cannot tolerate oral medications, intravenous valproate
sodium (Depacon) is quite effective and without severe side
effects, such as the addiction which accompanies opiate treatments
to stop the vomiting. See, Headache 40(9): 720 Oct. 2000.
Injections of Botox (killed botulinum toxin) into the scalp
muscles has been advocated by some neurologists as an excellent
remedy for chronic daily headache with a tension component,
since it relaxes the scalp muscles.
Some patients experience their headaches only at night during
sleep. These are called "hypnic headaches" and are
associated with the REM phase of sleep when serotonin and
norepinephrine production cease. Some sufferers of hypnic
headaches have OSA (obstructive sleep apnea) and they tend
to show improvement with CPAP (continuous positive airway
pressure) or surgery of the sinus or throat to remove the
obstruction. However, not all hypnic headache sufferers have
OSA. For the ones who do not, use of melatonin or Indomethicin
has brought some relief. Headache 40(9): 748 Oct. 2000.
Meditation with positive imaging can help tension headache
and bio-feedback may help migraine. SSRI antidepressants like
Prozac and Zoloft have not been established as effective in
relieving migraine. Some cluster headache and migraine patients
experience redness, tearing and burning sensations in their
eyes during a headache. These patients can benefit from Periactin.
People interested in tracking the development of new headache
medications may check a new government web site mandated by
Congress called www.ClinicalTrials.gov
|